Life history trade-offs in cancer evolution, Nature Rev. Cancer, vol.13, pp.883-892, 2013. ,
The origins of malignant tumors, 1929. ,
, Structure of Intratumor Heterogeneity: Is Cancer Hedging Its Bets? arXiv, 2013.
Ancestral gene regulatory networks drive cancer, vol.114, pp.6160-6162, 2017. ,
Optimization of an in vitro chemotherapy to avoid resistant tumours, J. Theor. Biol, vol.413, pp.24-33, 2017. ,
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation, Biochem. Biophys. Acta, vol.1860, pp.2627-2645, 2016. ,
The Impact of Competition Between Cancer Cells and Healthy Cells on Optimal Drug Delivery, Math. Mod. Nat. Phenom, 2019. ,
Ancient genes establish stress-induced mutation as a hallmark of cancer, PLoS One, vol.12, issue.4, p.176258, 2017. ,
Tumour cell heterogeneitymaintained by cooperating subclones in Wnt-driven mammary cancers, Nature Lett, vol.508, pp.113-117, 2014. ,
Cancer tumors as metazoa 1.0: tapping genes of ancient ancestors, Phys. Biol, vol.8, issue.1, p.15001, 2011. ,
Nothing in Biology Makes Sense Except in the Light of Evolution, American Biology Teacher, vol.35, issue.3, pp.125-129, 1973. ,
An ancient evolutionary origin of genes associated with human genetic diseases, Mol. Biol. Evol, vol.25, issue.12, pp.2699-2707, 2008. ,
Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa, BMC Biol, vol.8, issue.1, p.66, 2010. ,
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nat. Rev. Cancer, vol.12, issue.7, pp.487-493, 2012. ,
Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 1: Biological Facts and Studies in Drug Resistance, Current Stem Cell Reports, vol.3, pp.253-259, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01558477
Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, From Theoretical Biology to Mathematical Models, vol.2, pp.260-268, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01558477
Mechanisms of cancer drug resistance, Annu. Rev. Med, vol.53, pp.615-627, 2002. ,
Multidrug resistance in cancer: role of ATPdependent transporters, Nat. Rev. Cancer, vol.2, issue.1, pp.48-58, 2002. ,
Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia, Nature Comm, vol.7, p.12475, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01358183
Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy, Bull Math Biol, vol.80, issue.5, pp.954-970, 2017. ,
On the intrinsic inevitability of cancer: From foetal to fatal attraction, Sem. Canc. Biol, vol.21, pp.183-199, 2011. ,
Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells, Canc. Metastasis Rev, vol.32, pp.423-448, 2013. ,
Tumour progression: random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?, J. Theor. Biol, vol.178, issue.4, pp.375-380, 1996. ,
On selection dynamics for competitive interactions, J. Math. Biol, vol.63, pp.493-551, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00602077
Evolution and tinkering, Science, vol.196, issue.4295, pp.1161-1166, 1977. ,
Targeting cancers weaknesses (not its strengths): therapeutic strategies suggested by the atavistic model, Bioessays, vol.36, issue.9, pp.827-835, 2014. ,
Dissecting thedynamics of epigenetic changes in phenotype-structured populations exposed to fluctuating environments, J. Theor. Biol, vol.386, pp.166-176, 2015. ,
Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations, Biology Direct, vol.11, p.43, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01321535
Populational adaptive evolution, chemotherapeutic resistance and multiple anticancer therapies, ESAIM Math. Model. Numer. Anal, vol.47, issue.2, pp.377-399, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00714274
Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors, Bull. Math. Biol, vol.77, issue.1, p.122, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00921266
Intra-tumour heterogeneity: a looking glass for cancer?, Nature Rev. Cancer, vol.12, pp.323-334, 2012. ,
The major transitions in evolution, 1995. ,
Cooperation and conflict in the evolution of multicellularity, Heredity, vol.36, pp.1-7, 2001. ,
Cooperation and conflict during evolutionary transitions in individuality, J. Evol. Biol, vol.19, pp.1406-1409, 2006. ,
Life-history evolution and the origin of multicellularity, J. Theor. Biol, vol.239, pp.257-272, 2006. ,
Clonal cooperation, Nature, vol.508, pp.52-53, 2014. ,
Non-Darwinian dynamics in therapy-induced cancer drug resistance, Nat. Commun, vol.4, p.2467, 2013. ,
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me, Br. J. Cancer, vol.112, issue.11, pp.1725-1757, 2015. ,
Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy, J. Math. Pures Appl, vol.116, pp.268-308, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01673589
Global stability with selection in integrodifferential Lotka-Volterra systems modelling trait-structured populations, J. Biol. Dynamics, vol.12, issue.1, pp.872-893, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01470722
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, Cell, vol.141, pp.69-80, 2010. ,
Tumorigenesis: it takes a village, Nature Rev. Cancer, vol.15, pp.473-483, 2015. ,
Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors, vol.114, pp.6406-6411, 2017. ,
How the evolution of multicellularity set the stage for cancer, Br. J. Cancer, vol.118, pp.145-152, 2018. ,
Mechanisms of tumor promotion: possible role of inhibited intercellular communication, Eur. J. Cancer Clin. Oncol, vol.23, issue.6, pp.599-601, 1987. ,
Gap Junctional Intercellular Communication as a Biological "Rosetta Stone" in Understanding, in a Systems Biological Manner, Stem Cell Behavior, Mechanisms of Epigenetic Toxicology, Chemoprevention and Chemotherapy, J. Membrane Biol, vol.218, pp.93-100, 2007. ,
A conceptual integration of extra-, intra-and gap junctional-intercellular communication in the evolution of multi-cellularity and stem cells: how disrupted cell-cell communication during development can affect diseases later in life, Int. J. Stem Cell Res. Ther, vol.3, issue.1, p.21, 2016. ,
Cancer: a de-repression of a default survival program common to all cells?: a lifehistory perspective on the nature of cancer, Bioessays, vol.34, issue.1, pp.72-82, 2011. ,
The strategies of the genes, George Allen & Unwin, 1957. ,
Ancient hot and cold genes and chemotherapy resistance emergence, Proc. Nat. Acad. Sci, vol.112, pp.10467-10472, 2015. ,
Cancer genetics and epigenetics: two sides of the same coin?, Cancer Cell, vol.22, issue.1, pp.9-20, 2012. ,
Phylostratigraphic analysis of tumor and developmental transcriptomes reveals relationship between oncogenesis, phylogenesis and ontogenesis, Converg. Sci. Phys. Oncol, vol.4, p.25002, 2018. ,